Carol Kruchko
President & Chief Officer
Central Brain Tumor Registry of the United States (CBTRUS)
Cancer collection efforts in the United States provide clinically relevant data on all primary brain and other CNS tumors
Summary:
Cancer collection efforts in the United States provide clinically relevant data on all primary brain and other CNS tumors was recently published in Neuro-Oncology Practice, one of the Society for Neuro-Oncology journals. The authors described the role the Central Brain Tumor Registry of the United States (CBTRUS) had in championing the accurate and complete collection of all primary brain and other central nervous system (CNS) tumors in the United States. The manuscript provided a brief historical description by starting with the efforts of CBTRUS to expand cancer collection to include all brain and other CNS tumors coded with benign and uncertain behaviors and the support of surveillance stakeholders to utilize these data in the Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System. However, the main focus of the Neuro-Oncology Practice manuscript was to describe to the clinical community the collaborative efforts exerted by the cancer surveillance community, in particular the Site-Specific Data Items (SSDI) Task Force, to include all biomarkers listed in 2016 WHO Classification of Tumours of the Central Nervous System starting January 1, 2018.
Full Articles, HERE
